Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

18. Mai 2016 02:00 ET | Quelle: Midatech Pharma PLC

Midatech Pharma announces clinical pipeline update

ABINGDON, England, May 18, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing products...
11. Mai 2016 02:00 ET | Quelle: Midatech Pharma PLC

AGM Statement and Update on Trading

ABINGDON, England, May 11, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM: MTPH; Nasdaq: MTP), the international specialty pharmaceutical company focused on commercialising and developing...
29. Februar 2016 02:00 ET | Quelle: Midatech Pharma PLC

Midatech Pharma Recognises International Rare Disease Day 2016

ABINGDON, Va., Feb. 29, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH), (Nasdaq:MTP), the international specialty pharmaceutical company focused on developing and commercialising products in...
07. Januar 2016 16:00 ET | Quelle: Midatech Pharma PLC

Midatech Pharma to Present at Biotech Showcase™ 2016

OXFORD, United Kingdom, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on developing and commercialising...
06. Januar 2016 02:00 ET | Quelle: Midatech Pharma PLC

Midatech Pharma PLC (“Midatech”, the “Company” or the “Group”) Pre-Close Trading Update

OXFORD, United Kingdom, Jan. 06, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising...
04. Januar 2016 02:00 ET | Quelle: Midatech Pharma PLC

Midatech Signs Licensing Agreement With Emergex Vaccines

CAMBRIDGE, United Kingdom, Jan. 04, 2016 (GLOBE NEWSWIRE) -- Midatech Pharma (AIM:MTPH) (Nasdaq:MTP), the international specialty pharmaceutical company focused on developing and commercialising...